title: Preseptal cellulitis caused by community acquired methicillin resistant Staphylococcus aureus (CAMRSA).
authors.affiliation: Ophthalmology Department, Mater Misericordiae University Hospital, Eccles Street, Dublin 7, Ireland. sonia_charalampidou@yahoo.co.uk
authors.forename: Sofia
authors.initials: S
authors.lastname: Charalampidou
authors.forename: Paul
authors.initials: P
authors.lastname: Connell
authors.forename: Jerome
authors.initials: J
authors.lastname: Fennell
authors.forename: Maureen
authors.initials: M
authors.lastname: Lynch
authors.forename: Robert
authors.initials: R
authors.lastname: Acheson
mesh_terms: D000081:Acetamides / Q000008:administration & dosage / Q000627:therapeutic use; D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000627:therapeutic use; D000890:Anti-Infective Agents / Q000008:administration & dosage / Q000627:therapeutic use; D017714:Community-Acquired Infections; D004359:Drug Therapy, Combination; D005538:Football; D006801:Humans; D000069349:Linezolid; D008297:Male; D016106:Methicillin Resistance; D009883:Ophthalmic Solutions; D054517:Orbital Cellulitis / Q000382:microbiology* / Q000473:pathology; D023303:Oxazolidinones / Q000008:administration & dosage / Q000627:therapeutic use; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000503:physiopathology*; D013211:Staphylococcus aureus / Q000472:pathogenicity*; D014640:Vancomycin / Q000008:administration & dosage / Q000627:therapeutic use
chemical_list: D000081:Acetamides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D009883:Ophthalmic Solutions; D023303:Oxazolidinones; D014640:Vancomycin; D000069349:Linezolid